These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12120518)

  • 1. Alkylation of heme by the antimalarial drug artemisinin.
    Robert A; Coppel Y; Meunier B
    Chem Commun (Camb); 2002 Mar; (5):414-5. PubMed ID: 12120518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin.
    Selmeczi K; Robert A; Claparols C; Meunier B
    FEBS Lett; 2004 Jan; 556(1-3):245-8. PubMed ID: 14706857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme alkylation by artesunic acid and trioxaquine DU1301, two antimalarial trioxanes.
    Laurent SA; Loup C; Mourgues S; Robert A; Meunier B
    Chembiochem; 2005 Apr; 6(4):653-8. PubMed ID: 15744769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylation of manganese(II) tetraphenylporphyrin by antimalarial fluorinated artemisinin derivatives.
    Rodriguez M; Bonnet-Delpon D; Bégué JP; Robert A; Meunier B
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1059-62. PubMed ID: 12643911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of charge distribution on the antimalarial activity of artemisinin analogues.
    Rafiee MA; Hadipour NL; Naderi-manesh H
    J Chem Inf Model; 2005; 45(2):366-70. PubMed ID: 15807501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C10-modified artemisinin derivatives: efficient heme-alkylating agents.
    Laurent SA; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2005 Mar; 44(14):2060-3; author reply 2064-5. PubMed ID: 15782383
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and FE(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry.
    Pashynska VA; Van den Heuvel H; Claeys M; Kosevich MV
    J Am Soc Mass Spectrom; 2004 Aug; 15(8):1181-90. PubMed ID: 15276165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme as trigger and target for trioxane-containing antimalarial drugs.
    Meunier B; Robert A
    Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling and molecular docking study of translationally controlled tumor protein and artemisinin.
    Chae J; Choi I; Kim C
    Arch Pharm Res; 2006 Jan; 29(1):50-8. PubMed ID: 16491843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylation of microperoxidase-11 by the antimalarial drug artemisinin.
    Rodriguez M; Claparols C; Robert A; Meunier B
    Chembiochem; 2002 Nov; 3(11):1147-9. PubMed ID: 12404644
    [No Abstract]   [Full Text] [Related]  

  • 12. The antimalarial drug artemisinin alkylates heme in infected mice.
    Robert A; Benoit-Vical F; Claparols C; Meunier B
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13676-80. PubMed ID: 16155128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine.
    Loup C; Lelièvre J; Benoit-Vical F; Meunier B
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3768-70. PubMed ID: 17698628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action.
    Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D
    ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials.
    Creek DJ; Charman WN; Chiu FC; Prankerd RJ; Dong Y; Vennerstrom JL; Charman SA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1291-6. PubMed ID: 18268087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the decomposition mechanism of artemisinin.
    Moles P; Oliva M; Safont VS
    J Phys Chem A; 2006 Jun; 110(22):7144-58. PubMed ID: 16737265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin.
    Parapini S; Basilico N; Mondani M; Olliaro P; Taramelli D; Monti D
    FEBS Lett; 2004 Sep; 575(1-3):91-4. PubMed ID: 15388339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs.
    Robert A; Dechy-Cabaret O; Cazelles J; Meunier B
    Acc Chem Res; 2002 Mar; 35(3):167-74. PubMed ID: 11900520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferryl-oxo heme intermediate in the antimalarial mode of action of artemisinin.
    Kapetanaki S; Varotsis C
    FEBS Lett; 2000 Jun; 474(2-3):238-41. PubMed ID: 10838092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin.
    Zhang S; Gerhard GS
    Bioorg Med Chem; 2008 Aug; 16(16):7853-61. PubMed ID: 18676152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.